Autosomal dominant severe congenital neutropenia is a genetic condition that causes very low neutrophil counts from birth. People with Autosomal dominant severe congenital neutropenia have frequent or severe infections like pneumonia or skin infections. It starts in infancy and usually lasts lifelong, and not everyone will have the same experience. Treatment often includes daily granulocyte colony-stimulating factor injections and prompt antibiotics for infections. The risk of serious infection can be high without treatment, but many people live long and full lives with careful care.
Overview
Autosomal dominant severe congenital neutropeniaSymptoms
Autosomal dominant severe congenital neutropenia often appears in infancy with frequent infections, fever, and mouth ulcers. Early signs of autosomal dominant severe congenital neutropenia include slow-healing wounds and persistently low neutrophil counts on blood tests. Recurring infections deserve prompt care.
Outlook and prognosis
Many living with autosomal dominant severe congenital neutropenia do well long term with consistent care, infection prevention, and prompt treatment of fevers. Granulocyte colony‑stimulating factor often stabilizes neutrophil counts and daily life. Ongoing monitoring helps detect complications, including rare leukemic transformation.
Causes and risk factors
Autosomal dominant severe congenital neutropenia arises from a single-gene change, inherited or due to a new mutation. Family history is the main risk; when early symptoms of Autosomal dominant severe congenital neutropenia appear in relatives, risk is higher.
Genetic influences
Genetics play a central role in autosomal dominant severe congenital neutropenia, with single-copy (dominant) variants—often in ELANE—driving low neutrophil counts from birth. Family history increases risk, though new (de novo) variants also occur. Genetic testing guides diagnosis, prognosis, and family planning.
Diagnosis
Doctors suspect Autosomal dominant severe congenital neutropenia from recurring infections and very low neutrophil counts. Diagnosis is confirmed with bone marrow evaluation and genetic tests, supporting the genetic diagnosis of Autosomal dominant severe congenital neutropenia.
Treatment and drugs
Treatment for autosomal dominant severe congenital neutropenia focuses on preventing infections and boosting neutrophils. Many respond well to daily or intermittent G‑CSF injections, plus prompt antibiotics for infections and routine vaccines. Some need bone marrow transplant if G‑CSF is insufficient.
Symptoms
Frequent, sometimes serious bacterial infections are the main concern, often starting in the first months of life. Early on, this might look like fevers that come back, skin or mouth infections, or chest infections that need antibiotics or a hospital stay. People with autosomal dominant severe congenital neutropenia have very low numbers of a key white blood cell that fights bacteria, so everyday germs can cause bigger problems. Parents may notice early features of autosomal dominant severe congenital neutropenia such as mouth ulcers, swollen gums, or repeated ear and sinus infections.
Bacterial infections happen often and can be more severe than expected. They may involve the lungs, skin, ears, or bloodstream and often need prompt antibiotics.
Fevers happen often and may be the first sign of infection. In autosomal dominant severe congenital neutropenia, a fever without a clear source deserves prompt medical attention.
Painful mouth ulcers, swollen or bleeding gums, and dental problems are common. These can make eating uncomfortable and raise the risk of deeper mouth infections.
Red, tender areas or boils can develop, sometimes with little or no pus. In autosomal dominant severe congenital neutropenia, infections around the diaper area or near the anus are especially common in early life.
How people usually first notice Autosomal dominant severe congenital neutropenia?
Many families first notice something is wrong when a newborn or infant has frequent, unusually severe infections—like stubborn skin infections, pneumonia, mouth ulcers, or fevers that don’t match a mild cold. Doctors often pick up the pattern after repeat infections and a blood test showing very low neutrophils (a type of white blood cell that fights bacteria), leading them to consider the first signs of autosomal dominant severe congenital neutropenia. In some cases, a family history of early, serious infections or known gene changes prompts earlier testing, so that’s often how autosomal dominant severe congenital neutropenia is first noticed.
Types of Autosomal dominant severe congenital neutropenia
Autosomal dominant severe congenital neutropenia has a few well-recognized clinical variants tied to specific genes, and these variants can differ in age at first infections, response to treatments like G‑CSF, and long‑term risks such as bone marrow changes. Symptoms don’t always look the same for everyone. Clinicians often describe them in these categories to help explain patterns in severity, infection frequency, and chances of developing problems like bone pain or spleen enlargement; knowing the types of autosomal dominant severe congenital neutropenia can guide monitoring over time.
ELANE-related SCN
This common variant involves changes in the ELANE gene that disrupt neutrophil maturation. People often have very low neutrophil counts from infancy with frequent bacterial infections. Response to G‑CSF varies from strong to partial.
G6PC3-related SCN
This variant links low neutrophils with additional features like heart or kidney differences and visible veins under the skin. Infections can be recurrent but may come with extra‑hematologic signs that prompt genetic testing. Some respond well to G‑CSF, though monitoring for organ involvement is important.
CSF3R-related SCN
Changes affecting the G‑CSF receptor can blunt the marrow’s response to G‑CSF. People may have persistent severe neutropenia despite higher doses. Care teams often adjust therapy and watch closely for marrow changes.
WAS-related X‑linked
In rare cases with neutropenia and frequent infections, variants in the WAS gene present with low platelets and immune issues. This is an X‑linked condition and not autosomal dominant, but it can clinically mimic SCN early on. Genetic testing helps distinguish it and guides different management.
What genetics can tell you about symptoms
Some people with autosomal dominant severe congenital neutropenia have ELANE gene changes that disrupt neutrophil maturation, leading to very low infection‑fighting cells and frequent fevers, mouth ulcers, and serious bacterial infections. Certain variants cause cyclical dips, so symptoms flare every few weeks.
Causes and risk factors
Autosomal dominant severe congenital neutropenia is usually caused by a change in the ELANE gene that affects how certain white blood cells develop. Doctors distinguish between risk factors you can change and those you can’t. Having a parent with the gene change is the main non‑modifiable risk, and a new mutation can also happen without family history. Environment and daily habits do not cause it, but they can affect how often infections happen once the condition is present. Because these factors vary, early symptoms of autosomal dominant severe congenital neutropenia can look different from child to child.
Environmental and biological risk factors
Autosomal dominant severe congenital neutropenia is rare, and most families have no clear warning before a pregnancy. Some risks are carried inside the body, others come from the world around us. In this section, we focus on environmental and biological risk factors for autosomal dominant severe congenital neutropenia that may slightly raise the chance it occurs. Overall risk remains low, but understanding these factors can help guide planning.
As men get older, new changes can arise during sperm formation, which can raise the chance of rare conditions present from birth. For this condition, the absolute chance per pregnancy remains small.
High-dose exposure to ionizing radiation before conception can damage reproductive cells. This may slightly increase the chance of a child being born with this condition.
Past chemotherapy or pelvic radiation can temporarily affect sperm or eggs. Clinicians may suggest a waiting period before conception to lower any added risk.
Significant ionizing radiation in early pregnancy can disrupt blood-forming tissues as they develop. Medically necessary imaging generally uses low doses, but avoiding unnecessary exposure is prudent.
Genetic risk factors
Several inherited or new gene changes can lead to this condition, most often in the ELANE gene. Autosomal dominant severe congenital neutropenia is passed down when one altered copy of a gene is present, with a 50% chance for each child to inherit it. People with the same risk factor can have very different experiences. Genetic testing can identify the genetic causes of autosomal dominant severe congenital neutropenia and clarify family risks.
ELANE variants: ELANE variants account for most autosomal dominant severe congenital neutropenia cases. They disturb how early white blood cells mature in the bone marrow. Severity and blood counts can vary even within the same family.
GFI1 variants: Changes in GFI1 can also cause autosomal dominant severe congenital neutropenia. This gene helps control stages of white blood cell development. Some families show milder or variable findings.
CSF3R variants: Rare inherited changes in CSF3R, the receptor for a key growth signal, can lead to this condition. These changes reduce signals that normally help neutrophils grow and survive. Some affected relatives may have differing neutrophil levels over time.
SRP54 variants: Variants in SRP54 are an uncommon autosomal dominant cause. They can impair how cells make and process certain proteins needed for neutrophil formation. Some people also have features outside the blood system.
De novo variants: Many with autosomal dominant severe congenital neutropenia have a new genetic change not found in either parent. The variant arises in the egg, sperm, or early embryo. Siblings usually have a low chance of being affected unless a parent has mosaicism.
Family history: Having a parent with a confirmed pathogenic variant creates inherited risk for autosomal dominant severe congenital neutropenia. Each child then has a 50% chance to inherit the change. The age when low neutrophils first appear can differ between relatives.
Variable penetrance: Some autosomal dominant variants show incomplete penetrance. This means a person can carry the change but have few or no symptoms. When present, early symptoms of autosomal dominant severe congenital neutropenia usually begin in infancy.
Parental mosaicism: A parent may rarely have germline mosaicism, where only some egg or sperm cells carry the variant. In that case, a second child could be affected even if the parent’s blood test is negative. Discussing recurrence risk with a genetics team can refine planning for future pregnancies.
Lifestyle risk factors
Autosomal dominant severe congenital neutropenia is not caused by lifestyle, but daily habits can change infection risk, symptom burden, and complications. This summary focuses on how lifestyle affects Autosomal dominant severe congenital neutropenia with practical, condition-specific choices. Food, hygiene, activity, and exposure decisions can lower the frequency and severity of infections.
Frequent handwashing and alcohol-based sanitizer use lowers exposure to bacteria and viruses when neutrophils are low. Clean hands before eating, after public spaces, and after toileting to reduce febrile infections.
Follow neutropenia food precautions such as avoiding raw or undercooked meat, unpasteurized dairy, raw eggs, and raw sprouts. Wash produce well and separate raw from ready-to-eat foods to prevent gastrointestinal infections and bacteremia.
Brush gently twice daily, floss carefully, and use alcohol-free mouthwash to reduce gingivitis and mouth ulcers that can seed bloodstream infections. Regular dental checkups with preventive cleanings lower oral infection risk.
Moisturize dry skin, avoid razor nicks, and promptly clean and cover any cuts to prevent cellulitis and abscesses. Shower after sweating and change out of damp clothes to limit skin microbe overgrowth.
Risk prevention
While autosomal dominant severe congenital neutropenia is inherited, the condition itself can’t be prevented. The focus is on preventing infections and lowering long-term risks while watching for early symptoms of autosomal dominant severe congenital neutropenia. Prevention works best when combined with regular check-ups.
Keep recommended vaccines up to date to lower the chance of severe infections. Ask about flu and pneumococcal shots, and make sure close contacts are vaccinated too.
Wash hands often with soap and water or use sanitizer, especially before meals and after public places. This helps people with severe congenital neutropenia avoid everyday germs.
Treat any fever of 38.0°C (100.4°F) or higher as urgent. Have a clear plan for rapid assessment and antibiotics if your care team has advised it.
Take growth-factor shots exactly as prescribed to raise neutrophil levels. Regular dosing and lab checks help keep protection steady.
Transmission
Autosomal dominant severe congenital neutropenia is a genetic condition and is not contagious—you can’t catch it from someone else. The genetic transmission of Autosomal dominant severe congenital neutropenia is autosomal dominant: a single changed gene from an affected parent is enough to cause it, and each child has a 50% (1 in 2) chance of inheriting the condition. Sometimes it appears for the first time in a family because of a new gene change in the child, so there may be no family history.
When to test your genes
Consider genetic testing if you or a close relative had very low neutrophil counts from infancy, recurrent severe infections, or a known autosomal dominant SCN variant. Test before planning a pregnancy, when infections are frequent or severe, or if counts fluctuate despite treatment. Results can guide surveillance, G‑CSF dosing, transplant timing, and family screening.
Diagnosis
Diagnosis usually starts with a pattern of early, repeated infections and very low neutrophil counts in a baby or young child, then moves to tests that confirm the cause. Doctors look for features that fit a lifelong shortage of neutrophils and then use lab and genetic tests to pinpoint the type. Finding out the cause is the first step toward treatment. For families seeking a genetic diagnosis of Autosomal dominant severe congenital neutropenia, results can also guide care and future planning.
Recurrent fevers, skin infections, mouth sores, or pneumonia in early infancy raise suspicion. Many living with this condition have infections that seem frequent, severe, or slow to clear. Growth and energy may be affected during illness flares.
Doctors check for signs of ongoing or severe infections, such as mouth ulcers, skin abscesses, or swollen lymph nodes. They also look for wound healing problems and signs of inflammation. These features support a neutrophil problem.
A complete blood count shows persistently low neutrophils, often an absolute neutrophil count below 0.5 × 10^9/L (below 500/µL). Other white cells, red cells, and platelets may be in the usual range. Repeating the test confirms the low pattern over time.
Counts measured several times a week over 6–8 weeks help distinguish a constant severe neutropenia from a cycling pattern. Autosomal dominant severe congenital neutropenia typically shows stable, very low counts without regular ups and downs. This timing detail helps separate it from cyclic neutropenia.
Stages of Autosomal dominant severe congenital neutropenia
Autosomal dominant severe congenital neutropenia does not have defined progression stages. It usually appears from birth as persistently low neutrophils, with day-to-day impact driven by infections rather than a steady, stage-by-stage decline; early symptoms of autosomal dominant severe congenital neutropenia often include frequent fevers, mouth sores, and skin or ear infections. Different tests may be suggested to help confirm the diagnosis, including repeat blood counts showing a very low absolute neutrophil count (often under 0.5 × 10^9/L, or about 500/µL) and a bone marrow exam. Genetic testing can identify the underlying change and guides monitoring for complications over time, including the rare chance of progression to bone marrow problems.
Outlook and prognosis
Looking at the long-term picture can be helpful. For many people with autosomal dominant severe congenital neutropenia (SCN), the early years involve frequent infections and hospital visits, but consistent care lowers those risks over time. Early symptoms of autosomal dominant severe congenital neutropenia often include mouth ulcers, skin infections, and fevers that seem to come back just as one clears; daily life can feel like always having a plan for antibiotics and check-ins. With modern treatments such as granulocyte colony–stimulating factor (G‑CSF), most people see far fewer serious infections and are able to attend school or work more reliably.
The outlook is not the same for everyone, but it generally improves with steady treatment and infection-prevention habits. A key part of the prognosis is the small but real risk of blood complications over the years, including myelodysplastic syndrome or acute myeloid leukemia, especially in those needing higher G‑CSF doses; this is why regular blood counts and occasional bone marrow checks are recommended. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Some people experience rare infections after starting therapy, while others notice they still need periodic hospital care during flares.
Mortality has decreased significantly in the G‑CSF era, and many living with autosomal dominant SCN reach adulthood, work, and raise families. Stem cell transplant can be curative for select people with severe infections that don’t respond well or if concerning marrow changes appear, though it comes with its own risks and recovery period. Genetic testing can sometimes provide more insight into prognosis. Talk with your doctor about what your personal outlook might look like.
Long-term effects
People with autosomal dominant severe congenital neutropenia live with a lifelong tendency to serious infections and need ongoing monitoring. Long-term effects vary widely, and they can look different from childhood into adulthood. The long-term outlook for autosomal dominant severe congenital neutropenia depends on infection control and the small but real risk of bone marrow diseases over time. Many reach adulthood and beyond, though ongoing follow-up is typical to watch for changes.
Over years, recurrent skin, lung, and bloodstream infections can occur. Each episode can leave lasting effects, especially in the lungs and soft tissues.
Repeated pneumonias can lead to bronchiectasis and reduced lung function. In autosomal dominant severe congenital neutropenia, this can mean ongoing cough and infections that are harder to clear.
Chronic gum inflammation and periodontitis are common. Teeth may loosen or be lost earlier than expected.
Deep skin or soft-tissue infections can leave scars and stiffness. Some develop chronic wounds in areas that were repeatedly infected.
How is it to live with Autosomal dominant severe congenital neutropenia?
Living with autosomal dominant severe congenital neutropenia often means planning life around infection prevention and quick responses to fevers. Daily routines may include regular injections of G‑CSF, frequent blood counts, and being careful with crowds, raw foods, and even small skin injuries, because minor infections can escalate quickly. Many families and close friends become part of the safety net—helping with clinic visits, watching for early signs of infection, and supporting the emotional load that comes with constant vigilance. Over time, people often become skilled at balancing caution with normalcy, finding ways to stay active at school, work, and in relationships while keeping infections at bay.
Treatment and drugs
Treatment for autosomal dominant severe congenital neutropenia focuses on raising infection-fighting white cells, preventing infections, and managing complications. The mainstay is daily or near-daily injections of a growth factor that stimulates neutrophils (G‑CSF), with the dose adjusted to keep counts in a safer range while limiting side effects; a doctor may adjust your dose to balance benefits and side effects. Many people with autosomal dominant severe congenital neutropenia also need prompt antibiotics for fevers, good dental care, skin care, and up-to-date vaccines (non-live when appropriate), and your care team may recommend antifungal or antibiotic prevention if infections are frequent. If G‑CSF doesn’t work well enough, or if serious complications develop, a stem cell transplant from a matched donor may be considered as a potential cure, though it carries important risks and requires specialist evaluation. Because there’s a higher lifetime risk of bone marrow problems, including myelodysplastic syndrome or leukemia, regular monitoring with blood tests—and sometimes bone marrow checks—is part of long-term treatment.
Non-drug treatment
Living with autosomal dominant severe congenital neutropenia often means focusing on infection prevention in everyday life, at home, school, and work. Beyond prescriptions, supportive therapies can make day-to-day routines safer and more predictable. A clear plan for fevers and skin injuries helps reduce delays in care. Education for you and your family lowers worry and can catch early symptoms of autosomal dominant severe congenital neutropenia sooner.
Wash hands often and use alcohol-based sanitizer when soap and water aren’t available. Consider a well-fitted mask in crowded indoor spaces and avoid close contact with people who are unwell. These habits lower infection risk for people with autosomal dominant severe congenital neutropenia.
Eat fully cooked meats and eggs, choose pasteurized dairy, and avoid raw seafood or unwashed produce. Rinse fruits and vegetables well and keep leftovers refrigerated promptly. Safe water and clean kitchen surfaces further reduce exposure to germs.
Brush gently twice daily with a soft brush and floss carefully to limit gum injury. Schedule regular dental checkups and cleanings, and call your dentist early for mouth sores or bleeding. Warm saltwater rinses can soothe irritated gums.
Keep skin moisturized to reduce cracks, and trim nails carefully to avoid scratches. Clean any cuts right away, apply a clean covering, and watch for redness, swelling, or pus. People with autosomal dominant severe congenital neutropenia should contact their care team early if a wound looks infected.
Your genes may have an impact on how drugs work for you
Some medicines for autosomal dominant severe congenital neutropenia work better or cause more side effects depending on your genes, including how your body processes drugs and how bone marrow responds. Genetic testing can guide dosing and drug choice to improve safety and benefit.
Pharmacological treatments
For autosomal dominant severe congenital neutropenia, medicines focus on raising safe neutrophil levels and preventing or treating infections. Daily or long‑acting growth‑factor shots are the backbone, with antibiotics and antifungals used when infections occur or risk is high. Some people need adjustments over time to balance benefits and side effects. Alongside drug therapy, infection precautions and, in select cases, stem cell transplant remain important.
This daily injection boosts neutrophil production to lower infection risk. Dosing may be increased or lowered gradually to reach a stable neutrophil count with the fewest side effects.
Similar to filgrastim, this option is used in many countries to stimulate white blood cells. It may be chosen based on local availability and prior response.
A longer‑acting form that can reduce how often injections are needed. Some may still require tailored timing or additional doses to keep counts in a safe range.
Used when response to G‑CSF is limited or not tolerated. It works on related growth pathways and may help some people maintain higher neutrophil levels.
Genetic influences
In most families, this form is caused by a single change in a gene called ELANE; one altered copy is enough to disrupt how infection-fighting white blood cells (neutrophils) mature. Because it’s autosomal dominant, a parent who has the gene change has a 1 in 2 (50%) chance of passing it on to each child. Sometimes the change appears for the first time in a child (a new, or de novo, variant), so there may be no prior family history. Family history is one of the strongest clues to a genetic influence. Severity can differ from person to person, even among relatives with the same gene change, and the long-term risks may not be identical. Genetic testing for autosomal dominant severe congenital neutropenia can confirm an ELANE change, clarify recurrence risk, and help guide family planning or testing of relatives.
Is Autosomal dominant severe congenital neutropenia genetic?
Genetics play a central role in autosomal dominant severe congenital neutropenia, with single-copy (dominant) variants—often in ELANE—driving low neutrophil counts from birth. Family history increases risk, though new (de novo) variants also occur. Genetic testing guides diagnosis, prognosis, and family planning.
Pharmacogenetics—how genetics influence drug effects
In autosomal dominant severe congenital neutropenia, the specific gene change—most often in the ELANE gene—can influence how well medicines that boost white blood cells, such as granulocyte colony-stimulating factor (G‑CSF), work. Some people with ELANE variants respond to usual doses of filgrastim or pegfilgrastim, while others need higher doses, and a small number gain limited benefit, which may lead doctors to discuss stem cell transplant earlier. Pharmacogenetic testing doesn’t give a “yes or no” answer, but it can help estimate likely drug response in autosomal dominant severe congenital neutropenia and guide dose, timing, and monitoring. Over time, needing very high doses of G‑CSF and developing acquired changes in genes like CSF3R have been linked to a higher chance of bone marrow problems, so genetic results also shape how often doctors check blood counts and marrow health. Knowing the underlying mutation helps set expectations and choose the safest long‑term plan tailored to you.
Interactions with other conditions
Frequent bacterial and fungal infections can be more severe when autosomal dominant severe congenital neutropenia occurs alongside skin conditions like eczema, chronic sinus disease, or dental problems such as periodontitis, because breaks in the skin or gums give germs an easier way in. Viral illnesses, including the common cold or influenza, may temporarily push already low neutrophil counts even lower, so fevers or sore throats can escalate quickly into deeper infections like pneumonia. Early symptoms of autosomal dominant severe congenital neutropenia can resemble everyday infections, which sometimes delays recognizing that recurrent illness is part of a larger pattern. Certain medications used for other conditions—such as chemotherapy, some psychiatric drugs like clozapine, antithyroid medicines, or long courses of steroids—can further suppress white blood cells or blunt immune responses, raising the risk and severity of infections. Over time, there’s also a known connection with bone marrow disorders such as myelodysplastic syndrome or acute myeloid leukemia; if those develop, infection risk and anemia-related fatigue can compound one another. Ask if any medications for one condition might interfere with treatment for another.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of newborns with frequent, hard‑to-shake infections, while their parents or grandparents recalled similar early illnesses in the family. A baby might develop deep skin infections after a small scratch, or a toddler might have pneumonia that takes far longer than expected to clear. Long before modern testing, these clues hinted that something about infection‑fighting cells was different from birth.
First described in the medical literature as a severe form of infant neutropenia, early reports focused on repeated bacterial infections, mouth ulcers, and poor healing. Doctors could see very low neutrophil counts on blood tests, but the reason was unclear. In some families, several generations were affected, which raised early questions about inheritance. Over time, descriptions became more precise as clinicians distinguished this condition from cyclic neutropenia and other causes of low white cells in children.
From early theories to modern research, the story of autosomal dominant severe congenital neutropenia moved from careful bedside observation to the lab bench. As medical science evolved, bone marrow studies showed that early neutrophil precursors were present but failed to mature, helping explain why infections started so early in life. In recent decades, awareness has grown as newborn care improved and more infants survived long enough to be recognized and followed.
Advances in genetics confirmed a dominant inheritance pattern in many families and identified recurring gene changes that act like a faulty safety switch, pushing developing cells to stall or self‑destruct. This genetic clarity helped separate autosomal dominant severe congenital neutropenia from similar conditions and guided family counseling. It also explained why a parent with mild signs could still pass on a much more severe form to a child.
Treatment history has been equally important. Before targeted therapies, supportive care and prompt antibiotics were the main tools. The introduction of granulocyte colony‑stimulating factor (G‑CSF) in the late 20th century changed daily life for many people with autosomal dominant severe congenital neutropenia by boosting neutrophil counts and lowering infection risk. With each decade, long‑term follow‑up taught clinicians how to balance benefits with careful monitoring for complications.
Despite evolving definitions, the core picture has stayed the same: infections beginning in infancy, very low neutrophils, and a pattern that can run in families. Knowing the condition’s history helps explain why early symptoms of autosomal dominant severe congenital neutropenia are taken seriously today and why regular blood counts, genetics, and tailored treatment remain central to care.